62nd Annual Meeting

October 26 - 31, 2015

Roger S. McIntyre, MD, FRCPC

University Health Network, University of Toronto

• Advisory Board: Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; Lundbeck Inc; Merck & Co., Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Shire; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals U.S.A., Inc.
• Grant Support: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; Janssen Pharmaceuticals, Inc.; Lundbeck Inc; Pfizer Inc.; Shire; Sunovion Pharmaceuticals Inc.
• Speakers Bureau: AstraZeneca Pharmaceuticals LP; Eli Lilly and Company; Forest Laboratories, Inc.; Janssen Pharmaceuticals, Inc.; Lundbeck Inc; Merck & Co., Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals U.S.A., Inc.